[1]
M. C. García, “Treatment of borderline personality disorder with opioid antagonists: buprenorphine, nalmefene, naloxone and naltrexone in the treatment of dissociative symptoms, self-mutilation and suicidal behavior”, Vertex Rev Arg Psiquiatr, vol. 30, no. 148, nov.-dic., pp. 405–414, Dec. 2019.